comparemela.com

Latest Breaking News On - Analytical tool - Page 4 : comparemela.com

CAR/TCR Therapies in Oncology Analysis Tool: The Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer

/PRNewswire/ The "CAR/TCR Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. Your CAR/TCR Therapies in.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Gilead-sciences
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Novartis
Analytical-tool
Antigen-receptor

2022 Protein Kinase Inhibitors in Oncology Analytical Tool: Coverage of 508 Companies Plus Partners who are Developing 1668 PKI Drugs with 940 in Active Development in Across 322 Different Targets

/PRNewswire/ The "Protein Kinase Inhibitors in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. Protein Kinase.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Kinase-inhibitors
Analytical-tool
Protein-kinase-inhibitors
Business-development

Targeting the CD47-SIRPA Axis in Oncology Analytical Tool 2022: 70 Companies and Partners Developing 81 CD47-SIRPA Axis Targeting Drugs 76 in Active Development Across 28 Different Targets

/PRNewswire/ The "Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. Targeting the.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Conference-coverage
Companion-diagnostic-development
Therapy-choices
Analytical-tool

World Immune-checkpoint Drugs in Oncology Analysis 2022: Unparalleled Biomarker Surveillance & Access to Key Developments at the World-Leading Cancer Meetings

/PRNewswire/ The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. Immune-checkpoint Drugs.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Immune-checkpoint-drugs
Business-development
How-to-training-videos

2022 Bispecific CD3 Molecules in Oncology Analytical Tool: Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer

/PRNewswire/ The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. There is a considerable.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Conference-coverage
Companion-diagnostic-development
Therapy-choices

vimarsana © 2020. All Rights Reserved.